Search Within

David J Straus

Formats
  1. Meeting Abstract (168)
  2. Journal Article (166)
  3. Book Section (15)
  4. Conference Paper (5)
  5. Research Letter (3)
  6. Editorial (2)
  7. Correspondence (1)
  8. Review (1)
Groups
  1. Center for Hematologic Malignancies (361)
  2. Department of Medicine (361)
  3. Hematologic Malignancies, Division of (361)
  4. Lymphoma (361)
  5. Survivorship Research (162)
  6. Population Sciences Research Program (129)

More Groups

People
  1. Andrew Zelenetz (163)
  2. Ariela Noy (139)
  3. Paul Hamlin (122)
  4. Steven Horwitz (122)
  5. Craig Moskowitz (117)
  6. Matthew Matasar (104)

More People

Years
  1. 2024 (10)
  2. 2023 (9)
  3. 2022 (13)
  4. 2021 (27)
  5. 2020 (25)
  6. 2019 (21)

More Years

Publications
  1. Blood (117)
  2. Journal of Clinical Oncology (44)
  3. Hematological Oncology (19)
  4. Cancer (14)
  5. Leukemia and Lymphoma (13)
  6. British Journal of Haematology (11)

More Publications

Publishers
  1. American Society of Hematology (124)
  2. American Society of Clinical Oncology (46)
  3. Wiley Blackwell (36)
  4. Elsevier Inc. (23)
  5. Taylor & Francis Group (14)
  6. John Wiley & Sons (12)

More Publishers

Results (361)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of initial response on disease progression following tandem peripheral blood stem-cell transplants (PBSCT) in patients (pts) with poor prognosis multiple myeloma (MM)
    Meeting Abstract

    Niesvizky, R.; Choy, C. G.; Fine, J.; Glassman, J.; Reich, L.; Straus, D.; Yahalom, J.; Zhu, A.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with large cell lymphoma (LCL) treated with chop
    Meeting Abstract

    Donnelly, G. B.; Glassman, J.; Long, C.; Torres, P.; Straus, D. J.; O'Brien, J. P.; Zelenetz, A. D.; Moskowitz, C. H.; Portlock, C. S.
    Blood (1998)

    Fulltext@MSK | Save
  • Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Straus, D.; Portlock, C. S.; Goy, A.; O'Brien, J. P.; Zelenetz, A. D.
    Blood (1998)

    Fulltext@MSK | Save
  • Serial gallium scans in patients with bulky early stage Hodgkin's disease treated with chemotherapy and irradiation predict outcome
    Meeting Abstract

    Rini, J.; Yeung, H.; Macapinlac, H.; Myers, J.; Larson, S.; Yahalom, J.; Glassman, J.; Straus, D.
    Blood (1998)

    Fulltext@MSK | Save
  • A highly effective induction regimen for patients (PTS) with advanced, poor prognosis multiple myeloma (MM)
    Meeting Abstract

    Niesvizky, R.; Choy, C. G.; Zhu, A.; Fine, J.; Reich, L.; Straus, D.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142—Low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor
    Journal Article

    Straus, D. J.; Huang, J.; Testa, M. A.; Levine, A. M.; Kaplan, L. D.; for the National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Stem cell transplantation: Counterpoint
    Book Section

    Straus, D. J.
    In Johnson, F. E.; Virgo, K. S.; Edge, S. B.; Pellegrini, C. A.; Poston, G. J.; Schantz, S. P.; Tsukamoto, N. (Eds.) Cancer Patient Follow-up (1997)

    Fulltext@MSK | Save
  • Lymphoma: Counterpoint
    Book Section

    Straus, D. J.
    In Johnson, F. E.; Virgo, K. S.; Edge, S. B.; Pellegrini, C. A.; Poston, G. J.; Schantz, S. P.; Tsukamoto, N. (Eds.) Cancer Patient Follow-up (1997)

    Fulltext@MSK | Save
  • Prognostic factors in the treatment of HIV-associated non-Hodgkin lymphoma (HANHL): Analysis of ACTG 142 (low-dose vs. standard-dose mBACOD + GM-CSF)
    Meeting Abstract

    Straus, D. J.; Huang, J.; Testa, M. A.; Levine, A. M.; Kaplan, L. D.
    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology (1997)

    Fulltext@MSK | Save
  • Ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) cytoreduction followed by high dose chemoradiotherapy and ASCT for refractory and relapsed Hodgkin's disease (HD): An intent to treat study
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Portlock, C. S.; Straus, D. J.; Pearse, R.; O'Brien, J. P.; Berger, M.; Gardner, S.; Trippett, T. M.; Zelenetz, A. D.; more...
    Blood (1997)

    Fulltext@MSK | Save